Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Resveratrol (RSV) has been shown to have a renoprotective effect against diabetic nephropathy, but the underlying mechanisms of this have not been fully elucidated. The aim of the current study was to explore the mechanisms responsible for the therapeutic effects of RSV in rat mesangial cells in vitro and in a rat model of diabetic nephropathy. The viability of CRL‑2573 rat mesangial cells and their expression levels of p38, phosphorylated (p)‑p38, transforming growth factor beta 1 (TGF‑β1) and fibronectin were assessed in response to treatment with high glucose, with or without RSV. Diabetic nephropathy was also induced in Sprague‑Dawley rats by streptozotocin treatment. At 8 weeks, basic biochemical parameters and histopathological abnormalities as well as the expression of p38, p‑p38, TGF-β1 and fibronectin in rat kidneys were compared between control diabetic rats and those treated with 20 mg/kg RSV daily for 4 weeks. In the mesangial cell line, RSV inhibited high glucose‑induced increases in cell viability and fibronectin expression by significantly reducing p38 mitogen‑activated protein kinase (MAPK) activation and TGF‑β1 expression (P<0.05). In diabetic rats, RSV significantly decreased blood glucose, serum creatinine and urinary albumin levels, as well as the kidney weight and ratio of kidney weight/body weight compared with the control group (P<0.05). Moreover, RSV ameliorated renal histological changes and downregulated the expression of p‑p38, TGF‑β1 and fibronectin in the kidneys of diabetic rats. These data suggested that RSV protected renal tissue from diabetes‑induced injury and that this activity may be via inhibition of the p38 MAPK/TGF‑β1 signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haohao, Z., Guijun, Q., Juan, Z., Wen, K., & Lulu, C. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0392-1 · Cited by 42
Cited by
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review
Meng, X., Zhou, J., Zhao, C.-N., Gan, R.-Y., & Li, H.-B. (2020) · Foods · doi:10.3390/foods9030340 · Cited by 387
“Resveratrol also protected against diabetic complications such as myocardial fibrosis, diabetic nephropathy, and erectile dysfunction [11,88,94].”
BackgroundHuang, D.-D., Shi, G., Jiang, Y., Yao, C., & Zhu, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109767 · Cited by 229
Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
Wang, N., & Zhang, C. (2024) · Antioxidants · doi:10.3390/antiox13040455 · Cited by 218
Protective effects of plant‐derived natural products on renal complications
Yaribeygi, H., Simental‐Mendía, L. E., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27950 · Cited by 46
Metadata
- Authors
- Qiao, Y., Gao, K., Wang, Y., Wang, X., & Cui, B.
- Venue
- Experimental and Therapeutic Medicine
- Publisher
- Spandidos Publications
- Published
- 2017-05-04
- Volume
- 13
- Issue
- 6
- Pages
- 3223-3230
- ISSN
- 1792-0981 (ISSN-L)
- 1792-1015
- OpenAlex
- W2610256312
- Cited by
- 77
- References
- 1
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.